OKUR

OnKure Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Leverone Jason A.Chief Financial Officer
$1.3k303 shares
SellJun 22, 2026
$4.40
$4.34
Saccomano Nicholas ADirector, Officer: President And CEO
$37886 shares
SellJun 22, 2026
$4.40
$4.34
Leverone Jason A.Chief Financial Officer
$4.9k1.8k shares
SellApr 7, 2025
$2.67
--
Leverone Jason A.Chief Financial Officer
$4.3k1.3k shares
SellApr 4, 2025
$3.33
--
Saccomano Nicholas ADirector, Officer: President And CEO
$1.4k516 shares
SellApr 7, 2025
$2.67
--
Saccomano Nicholas ADirector, Officer: President And CEO
$1.2k358 shares
SellApr 4, 2025
$3.33
--

News

globenewswire.comOnKure Therapeutics Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 5globenewswire.comOnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomaliesglobenewswire.comMar 27globenewswire.comOnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Resultsglobenewswire.comMar 12